R&D Making a difference for traumatic brain injury patients TBI is the leading cause of death and disability in young adults in the developed world.
R&D Allogeneic therapies: The future of cancer treatment? Allogeneic therapies could provide an answer to some of the drawbacks of autologous therapies.
R&D 12 Questions with Ben Wiegand 12 Question with Ben Wiegand: transforming healthcare from disease care to health care.
R&D IWD: Aline Gégout on women in STEM To mark International Women’s Day 2023, we caught up with Aline Gégout of Roche Diabetes Care.
R&D Turning the NHS into a world-leading R&D platform Lord James O'Shaughnessy sets out the basis of his forthcoming independent review.
R&D Future of generative AI in pharma Talk of implementing automation and AI to enhance human capacity is dominating conversations.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
